Cytotoxicity of troglitazone through PPAR?-independent pathway and p38 MAPK ... - UroToday PDF Print
UroToday
The aim was to investigate the cytotoxicity of troglitazone (TGZ) and its mechanisms in terms of PPAR? dependency and the p38 mitogen-activated protein kinase (MAPK) pathway in three human renal cell carcinoma (RCC) cell lines, 786-O, Caki-2 and ACHN

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.